AstraZeneca Beats Expectations, Raises Guidance for the Year
AstraZeneca, the Anglo-Swedish pharmaceutical giant, has raised its full-year guidance following a strong second-quarter performance. The company now expects...
Tagrisso
Advancements in Lung Cancer Treatment: A New Hope for Patients
Lead: Lung cancer, once a death sentence, now offers more hope than ever with groundbreaking treatments extending survival for...
AstraZeneca Shares Surge on U.S. Approval of Tagrisso
Lead: AstraZeneca's shares surge as its lung-cancer treatment Tagrisso, combined with chemotherapy, receives U.S. approval, showing significant progress in...
AstraZeneca Shares Drop on Weak Quarterly Print, but Forecasts Double-Digit Growth in 2024
AstraZeneca, the pharmaceuticals major, has projected double-digit growth in revenue and core earnings per share for 2024, despite reporting...
Genprex Shares Surge on Positive Trial Progress
Genprex shares surged 15% after enrolling and dosing the first non-small cell lung cancer patient in a Phase 2...